Search

everythinglearnresearchcommunity

for

Search:↓

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Finasteride-loaded nanoparticles were successfully created for potential improved hair growth treatment.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

The shampoo with salicylic acid, panthenol, and niacinamide is effective and safe for preventing hair loss in people with alopecia.

The compound was successfully made and shows potential for treating prostate cancer.

Different enzymes are active in different parts of developing mouse organs.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Selenium and vitamin E supplements have mixed effects on prostate cancer risk and may not be beneficial for everyone.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Pumpkin seed oil may improve prostate health, bladder control, and hair growth in men.